bluebird bio IncNASDAQ:BLUENASDAQ FSI:E. Delinquent (Issuer missed regulatory filing deadline)
- LAST PRICE1.3200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.2100/ 40
- Ask / Lots1.3200/ 21
- Open / Previous Close0.0000 / 1.3200
- Day Range---
- 52 Week Range
- Volume184
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLUE |
|---|---|---|
| 09:32 ET | 87320 | 1.21 |
| 09:34 ET | 33824 | 1.2098 |
| 09:36 ET | 31697 | 1.22 |
| 09:38 ET | 4413 | 1.22 |
| 09:39 ET | 18352 | 1.23 |
| 09:41 ET | 4096 | 1.2201 |
| 09:43 ET | 53425 | 1.225 |
| 09:45 ET | 108909 | 1.244 |
| 09:48 ET | 71177 | 1.2592 |
| 09:50 ET | 66644 | 1.24 |
| 09:52 ET | 16771 | 1.245 |
| 09:54 ET | 10470 | 1.245 |
| 09:56 ET | 77364 | 1.255 |
| 09:57 ET | 29463 | 1.2501 |
| 09:59 ET | 51466 | 1.2599 |
| 10:01 ET | 52043 | 1.255 |
| 10:03 ET | 138252 | 1.255 |
| 10:06 ET | 49426 | 1.265 |
| 10:08 ET | 28553 | 1.26 |
| 10:10 ET | 72003 | 1.2686 |
| 10:12 ET | 84310 | 1.275 |
| 10:14 ET | 62113 | 1.2509 |
| 10:15 ET | 45832 | 1.251 |
| 10:17 ET | 45674 | 1.25 |
| 10:19 ET | 816 | 1.245 |
| 10:21 ET | 151752 | 1.23 |
| 10:24 ET | 38738 | 1.24 |
| 10:26 ET | 130282 | 1.24 |
| 10:28 ET | 6810 | 1.238 |
| 10:30 ET | 1206 | 1.235 |
| 10:32 ET | 368 | 1.24 |
| 10:33 ET | 8500 | 1.235 |
| 10:35 ET | 3886 | 1.235 |
| 10:37 ET | 30196 | 1.24 |
| 10:39 ET | 800 | 1.235 |
| 10:42 ET | 6900 | 1.235 |
| 10:44 ET | 19562 | 1.231 |
| 10:46 ET | 111347 | 1.23 |
| 10:48 ET | 23186 | 1.22 |
| 10:50 ET | 60656 | 1.22 |
| 10:51 ET | 27101 | 1.2196 |
| 10:53 ET | 26327 | 1.22 |
| 10:55 ET | 3900 | 1.22 |
| 10:57 ET | 33141 | 1.22 |
| 11:00 ET | 52471 | 1.215 |
| 11:02 ET | 34412 | 1.22 |
| 11:04 ET | 12100 | 1.2292 |
| 11:06 ET | 22290 | 1.23 |
| 11:08 ET | 1649 | 1.24 |
| 11:09 ET | 550 | 1.2399 |
| 11:11 ET | 700 | 1.24 |
| 11:13 ET | 41016 | 1.245 |
| 11:15 ET | 34238 | 1.245 |
| 11:18 ET | 1511 | 1.245 |
| 11:20 ET | 4999 | 1.25 |
| 11:22 ET | 61158 | 1.26 |
| 11:24 ET | 6359 | 1.2595 |
| 11:26 ET | 33374 | 1.2595 |
| 11:27 ET | 37839 | 1.26 |
| 11:29 ET | 12090 | 1.26 |
| 11:31 ET | 7767 | 1.2548 |
| 11:33 ET | 6613 | 1.259 |
| 11:36 ET | 17006 | 1.255 |
| 11:38 ET | 21285 | 1.255 |
| 11:40 ET | 10252 | 1.2595 |
| 11:42 ET | 8740 | 1.255 |
| 11:44 ET | 46169 | 1.2614 |
| 11:45 ET | 33038 | 1.265 |
| 11:47 ET | 14299 | 1.26 |
| 11:49 ET | 3995 | 1.2558 |
| 11:51 ET | 2546 | 1.255 |
| 11:54 ET | 10596 | 1.27 |
| 11:56 ET | 22510 | 1.27 |
| 11:58 ET | 18493 | 1.2699 |
| 12:00 ET | 190190 | 1.2994 |
| 12:02 ET | 26188 | 1.2986 |
| 12:03 ET | 35118 | 1.295 |
| 12:05 ET | 19313 | 1.3 |
| 12:07 ET | 57185 | 1.295 |
| 12:09 ET | 44123 | 1.295 |
| 12:12 ET | 91890 | 1.3 |
| 12:14 ET | 82039 | 1.2905 |
| 12:16 ET | 6367 | 1.295 |
| 12:18 ET | 34711 | 1.295 |
| 12:20 ET | 47390 | 1.3 |
| 12:21 ET | 20250 | 1.295 |
| 12:23 ET | 4300 | 1.295 |
| 12:25 ET | 8143 | 1.295 |
| 12:27 ET | 15890 | 1.3 |
| 12:30 ET | 8100 | 1.295 |
| 12:32 ET | 49246 | 1.285 |
| 12:34 ET | 23515 | 1.285 |
| 12:36 ET | 16300 | 1.29 |
| 12:38 ET | 68335 | 1.275 |
| 12:39 ET | 40005 | 1.27 |
| 12:41 ET | 1179 | 1.27 |
| 12:43 ET | 13581 | 1.28 |
| 12:45 ET | 18598 | 1.27 |
| 12:48 ET | 17872 | 1.26 |
| 12:50 ET | 2178 | 1.255 |
| 12:52 ET | 13497 | 1.2599 |
| 12:54 ET | 1906 | 1.26 |
| 12:56 ET | 1543 | 1.26 |
| 12:57 ET | 25349 | 1.2599 |
| 12:59 ET | 13923 | 1.26 |
| 01:01 ET | 800 | 1.26 |
| 01:03 ET | 6088 | 1.26 |
| 01:06 ET | 1633 | 1.255 |
| 01:08 ET | 14402 | 1.26 |
| 01:10 ET | 12622 | 1.255 |
| 01:12 ET | 11877 | 1.26 |
| 01:14 ET | 13288 | 1.26 |
| 01:15 ET | 16936 | 1.26 |
| 01:17 ET | 2370 | 1.265 |
| 01:19 ET | 1000 | 1.265 |
| 01:21 ET | 1475 | 1.265 |
| 01:24 ET | 16514 | 1.2695 |
| 01:26 ET | 4900 | 1.27 |
| 01:28 ET | 6507 | 1.265 |
| 01:30 ET | 814 | 1.265 |
| 01:32 ET | 3520 | 1.265 |
| 01:33 ET | 18572 | 1.2665 |
| 01:35 ET | 140393 | 1.255 |
| 01:37 ET | 1950 | 1.25 |
| 01:39 ET | 2670 | 1.255 |
| 01:42 ET | 1600 | 1.25 |
| 01:44 ET | 1600 | 1.26 |
| 01:46 ET | 24535 | 1.255 |
| 01:48 ET | 2341 | 1.26 |
| 01:50 ET | 1300 | 1.26 |
| 01:51 ET | 6547 | 1.2597 |
| 01:53 ET | 30885 | 1.26 |
| 01:55 ET | 29754 | 1.269 |
| 01:57 ET | 7300 | 1.27 |
| 02:00 ET | 2700 | 1.2682 |
| 02:02 ET | 2532 | 1.27 |
| 02:04 ET | 49039 | 1.28 |
| 02:06 ET | 1700 | 1.28 |
| 02:08 ET | 13435 | 1.275 |
| 02:09 ET | 3492 | 1.28 |
| 02:11 ET | 1500 | 1.28 |
| 02:13 ET | 14016 | 1.28 |
| 02:15 ET | 1300 | 1.28 |
| 02:18 ET | 2898 | 1.2798 |
| 02:20 ET | 7755 | 1.2701 |
| 02:22 ET | 129078 | 1.28 |
| 02:24 ET | 12797 | 1.2801 |
| 02:26 ET | 20665 | 1.285 |
| 02:27 ET | 3748 | 1.29 |
| 02:29 ET | 18200 | 1.2801 |
| 02:31 ET | 1470 | 1.29 |
| 02:33 ET | 120790 | 1.2905 |
| 02:36 ET | 25499 | 1.3 |
| 02:38 ET | 14600 | 1.3 |
| 02:40 ET | 18862 | 1.3 |
| 02:42 ET | 395637 | 1.31 |
| 02:44 ET | 14770 | 1.31 |
| 02:45 ET | 14498 | 1.31 |
| 02:47 ET | 51421 | 1.3119 |
| 02:49 ET | 21031 | 1.32 |
| 02:51 ET | 48874 | 1.32 |
| 02:54 ET | 45253 | 1.31 |
| 02:56 ET | 33685 | 1.3115 |
| 02:58 ET | 79062 | 1.33 |
| 03:00 ET | 70683 | 1.3198 |
| 03:02 ET | 18175 | 1.32 |
| 03:03 ET | 8000 | 1.32 |
| 03:05 ET | 93920 | 1.31 |
| 03:07 ET | 22187 | 1.32 |
| 03:09 ET | 13014 | 1.32 |
| 03:12 ET | 22570 | 1.32 |
| 03:14 ET | 7584 | 1.32 |
| 03:16 ET | 348168 | 1.345 |
| 03:18 ET | 38050 | 1.3478 |
| 03:20 ET | 16381 | 1.35 |
| 03:21 ET | 88894 | 1.3555 |
| 03:23 ET | 16150 | 1.356 |
| 03:25 ET | 67863 | 1.3552 |
| 03:27 ET | 95483 | 1.3499 |
| 03:30 ET | 51657 | 1.35 |
| 03:32 ET | 27244 | 1.3599 |
| 03:34 ET | 102732 | 1.345 |
| 03:36 ET | 14892 | 1.345 |
| 03:38 ET | 30511 | 1.345 |
| 03:39 ET | 13655 | 1.34 |
| 03:41 ET | 83116 | 1.33 |
| 03:43 ET | 37682 | 1.32 |
| 03:45 ET | 19498 | 1.325 |
| 03:48 ET | 53768 | 1.319 |
| 03:50 ET | 50756 | 1.315 |
| 03:52 ET | 81587 | 1.315 |
| 03:54 ET | 40105 | 1.315 |
| 03:56 ET | 182803 | 1.32 |
| 03:57 ET | 51456 | 1.315 |
| 03:59 ET | 70333 | 1.32 |
Jul 12, 2024
Jul 3, 2024
bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Wednesday Jul 03, 2024 by Dow Jones
4:05PM ET on Wednesday Jul 03, 2024 by Dow Jones
Jul 2, 2024
Lifshitz Law PLLC Announces Investigations of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), bluebird bio, inc. (NASDAQ:BLUE), Nextdoor Holdings, Inc. (NYSE:KIND), and Ventyx Biosciences, Inc. (NASDAQ:VTYX), from 11:56PM ET on Tuesday Jul 02, 2024 by Dow Jones
11:56PM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 27, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
bluebird bio Inc | 251.3M | -1.8x | --- |
Design Therapeutics Inc | 253.1M | -4.3x | --- |
Rezolute Inc | 249.2M | -4.3x | --- |
ESSA Pharma Inc | 248.9M | -8.9x | --- |
Century Therapeutics Inc | 232.4M | -1.2x | --- |
Monte Rosa Therapeutics Inc | 254.9M | -1.7x | --- |
Company Information
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).
Contact Information
- Headquarters
- 455 Grand Union BoulevardSOMERVILLE, MA, United States 02145
- Phone
- 339-499-9300
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Mark Vachon
- President, Chief Executive Officer, Director
- Andrew Obenshain
- Chief Financial Officer
- O. James Sterling
- Chief Commercial and Operating Officer
- Thomas Klima
- Chief Medical Officer
- Richard Colvin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $251.3M |
|---|---|
Revenue (TTM) | $21.7M |
Shares Outstanding | 190.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.87 |
EPS | $-0.74 |
Book Value | $2.37 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 11.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -626.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
